9.57
price up icon3.80%   0.35
after-market Handel nachbörslich: 9.57
loading
Schlusskurs vom Vortag:
$9.22
Offen:
$9.25
24-Stunden-Volumen:
800.94K
Relative Volume:
0.82
Marktkapitalisierung:
$617.03M
Einnahmen:
$202.09M
Nettoeinkommen (Verlust:
$-61.69M
KGV:
-8.8611
EPS:
-1.08
Netto-Cashflow:
$-35.64M
1W Leistung:
+3.24%
1M Leistung:
+3.13%
6M Leistung:
-32.27%
1J Leistung:
-22.26%
1-Tages-Spanne:
Value
$9.18
$9.69
1-Wochen-Bereich:
Value
$9.12
$9.69
52-Wochen-Spanne:
Value
$8.67
$17.82

Evolus Inc Stock (EOLS) Company Profile

Name
Firmenname
Evolus Inc
Name
Telefon
(949) 284-4555
Name
Adresse
520 NEWPORT CENTER DRIVE, NEWPORT BEACH
Name
Mitarbeiter
372
Name
Nächster Verdiensttermin
2025-03-04
Name
Neueste SEC-Einreichungen
Name
EOLS's Discussions on Twitter

Vergleichen Sie EOLS mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - Specialty & Generic icon
EOLS
Evolus Inc
9.57 597.69M 202.09M -61.69M -35.64M -1.08
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
151.19 68.05B 9.29B 2.52B 2.28B 5.57
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.55 46.58B 30.08B 710.16M 4.45B 0.2182
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.65 43.71B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
16.29 18.40B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
297.89 13.23B 2.99B 1.21B 1.13B 25.06

Evolus Inc Stock (EOLS) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-04-17 Eingeleitet BTIG Research Buy
2024-01-29 Hochstufung Barclays Equal Weight → Overweight
2022-06-23 Eingeleitet Needham Buy
2022-05-12 Hochstufung Barclays Underweight → Equal Weight
2022-01-20 Hochstufung Truist Hold → Buy
2021-05-06 Hochstufung Mizuho Neutral → Buy
2021-04-08 Bestätigt H.C. Wainwright Buy
2021-02-24 Herabstufung Truist Buy → Hold
2020-07-07 Herabstufung Mizuho Buy → Neutral
2020-02-06 Fortgesetzt Mizuho Buy
2019-11-26 Eingeleitet SVB Leerink Outperform
2019-09-05 Fortgesetzt Mizuho Buy
2019-06-28 Eingeleitet Wells Fargo Market Perform
2019-06-11 Eingeleitet Barclays Underweight
2019-03-20 Eingeleitet SunTrust Buy
2019-02-14 Eingeleitet H.C. Wainwright Buy
2019-01-29 Eingeleitet Stifel Buy
Alle ansehen

Evolus Inc Aktie (EOLS) Neueste Nachrichten

pulisher
Jul 22, 2025

Evolus Inc. Stock Analysis and ForecastDynamic investment opportunities - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Is Evolus Inc. a good long term investmentFree Risk Assessment Services - Autocar Professional

Jul 22, 2025
pulisher
Jul 22, 2025

Evolus to Report Second Quarter Financial Results on August 5, 2025 - Yahoo Finance

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about Evolus Inc. stockFree Stock Selection - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

What drives Evolus Inc. stock priceFree Predictions - Autocar Professional

Jul 21, 2025
pulisher
Jul 21, 2025

EvolusA Slightly Risky Buy Ahead Of Q2 Earnings (NASDAQ:EOLS) - Seeking Alpha

Jul 21, 2025
pulisher
Jul 18, 2025

Midday Stock Roundup: loanDepot Up 10% with High Volume - Orange County Business Journal

Jul 18, 2025
pulisher
Jul 15, 2025

How Evolus Inc. stock performs during market volatilityInsider Level Guidance - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Evolus Inc. stock price move sharplyTop Analyst Picks - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Evolus Inc. stock attracts strong analyst attentionRisk Controlled Trading Ideas - Newser

Jul 15, 2025
pulisher
Jul 14, 2025

Evolus announces inducement grants - Medical Buyer

Jul 14, 2025
pulisher
Jul 14, 2025

Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)July 11, 2025 - BioSpace

Jul 14, 2025
pulisher
Jul 11, 2025

How reliable are EOLS's earnings forecasts historically? - AInvest

Jul 11, 2025
pulisher
Jul 11, 2025

Is EOLS's Q1 2025 earnings forecast optimistic? - AInvest

Jul 11, 2025
pulisher
Jul 09, 2025

Evolus Expands into French Market - Orange County Business Journal

Jul 09, 2025
pulisher
Jul 09, 2025

EOLS Partners with Symatese for Nuceiva Distribution in France | - GuruFocus

Jul 09, 2025
pulisher
Jul 09, 2025

Fastest-Growing Botox Alternative Nuceiva Enters French Beauty Market Through Strategic Partnership - Stock Titan

Jul 09, 2025
pulisher
Jul 09, 2025

Evolus Expands Global Footprint with Introduction of Nuceiva® (botulinum toxin type A) in France - Yahoo Finance

Jul 09, 2025
pulisher
Jun 25, 2025

Trade Alert: President Of Evolus David Moatazedi Has Sold Stock - simplywall.st

Jun 25, 2025
pulisher
Jun 24, 2025

Where are the Opportunities in (EOLS) - news.stocktradersdaily.com

Jun 24, 2025
pulisher
Jun 20, 2025

When Can We Expect A Profit From Evolus, Inc. (NASDAQ:EOLS)? - Yahoo Finance

Jun 20, 2025
pulisher
Jun 18, 2025

Evolus (NASDAQ:EOLS) Shares Down 5.5% on Insider Selling - Defense World

Jun 18, 2025
pulisher
Jun 14, 2025

(EOLS) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com

Jun 14, 2025
pulisher
Jun 13, 2025

Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | EOLS Stock News - GuruFocus

Jun 13, 2025
pulisher
Jun 13, 2025

Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - MarketScreener

Jun 13, 2025
pulisher
Jun 12, 2025

Mizuho Securities Reaffirms Their Buy Rating on Evolus (EOLS) - The Globe and Mail

Jun 12, 2025
pulisher
Jun 11, 2025

Evolus Inc (EOLS) Stock Price Up 3.95% on Jun 11 - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Insider Spends US$189k Buying More Shares In Evolus - simplywall.st

Jun 11, 2025
pulisher
Jun 10, 2025

Insider Buying: White Albert G III Acquires 20,000 Shares of Evolus Inc (EOLS) - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

EOLS Director Boosts Stake with Significant Share Purchase | EOLS Stock News - GuruFocus

Jun 10, 2025

Finanzdaten der Evolus Inc-Aktie (EOLS)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$72.34
price up icon 1.09%
$14.93
price up icon 1.70%
$9.24
price up icon 3.82%
drug_manufacturers_specialty_generic RDY
$14.41
price down icon 0.96%
$132.75
price up icon 0.70%
$297.89
price up icon 1.63%
Kapitalisierung:     |  Volumen (24h):